WallStreetZenWallStreetZen

NASDAQ: ACIU
Ac Immune Sa Earnings & Revenue

ACIU past revenue growth

How has ACIU's revenue growth performed historically?
Company
316.44%
Industry
165.61%
Market
17.84%
ACIU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ACIU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ACIU's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ACIU earnings and revenue history

Current Revenue
$17.6M
Current Earnings
-$64.6M
Current Profit Margin
-366.4%

ACIU Return on Equity

Current Company
-37.5%
Current Industry
-63.6%
Current Market
188%
ACIU's Return on Equity (-37.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ACIU announces earnings.

ACIU Return on Assets

Current Company
-33.3%
Current Industry
3%
ACIU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ACIU Return on Capital Employed

Current Company
-31.94%
Current Industry
19.6%
ACIU's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ACIU vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ACIU$16.82M-$58.90M-$61.63M+20.10%N/A
ADVM$3.60M-$99.57M-$117.17M+17.43%N/A
FENC$13.05M-$17.00M-$20.22M+776.22%N/A
VSTM$0.00-$83.34M-$87.37M-100.00%N/A
FHTX$34.16M-$85.54M-$98.43M+428.05%N/A

ACIU earnings dates

Next earnings date
Apr 26, 2024

Ac Immune Sa Earnings & Revenue FAQ

What were ACIU's earnings last quarter?

On Invalid Date, Ac Immune Sa (NASDAQ: ACIU) reported Q4 2023 earnings per share (EPS) of -$0.06, up 75.71% year over year. Total Ac Immune Sa earnings for the quarter were -$5.65 million. In the same quarter last year, Ac Immune Sa's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Ac Immune Sa stock.

What was ACIU's earnings growth in the past year?

As of Q1 2024, Ac Immune Sa's earnings has grown year over year. Ac Immune Sa's earnings in the past year totalled -$61.63 million.

What is ACIU's earnings date?

Ac Immune Sa's earnings date is Invalid Date. Add ACIU to your watchlist to be reminded of ACIU's next earnings announcement.

What was ACIU's revenue last quarter?

On Invalid Date, Ac Immune Sa (NASDAQ: ACIU) reported Q4 2023 revenue of $17.62 million up 1,638,991.91% year over year. In the same quarter last year, Ac Immune Sa's revenue was $1.08 thousand.

What was ACIU's revenue growth in the past year?

As of Q1 2024, Ac Immune Sa's revenue has grown 316.44% year over year. This is 150.83 percentage points higher than the US Biotechnology industry revenue growth rate of 165.61%. Ac Immune Sa's revenue in the past year totalled $16.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.